Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis

Annals of Allergy, Asthma and Immunology

Volumn 95, Issue 3, 2005, Pages 272-282

  Lange, Bernd ^a,d   Lukat, Karl Friedrich ^a   Rettig, Klaus ^b   Holtappels, Gabriele ^c   Bachert, Claus ^c  

^a Institut fur Atemwegsforschung GmbH   (Germany)

^b G E M Gesellschaft für Evaluation und Qualitätssicherung in der Medizin mbH   (Germany)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

^d NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CROMOGLYCATE DISODIUM; LEVOCABASTINE; MOMETASONE FUROATE; NOSE SPRAY;

ADULT; ALLERGIC RHINITIS; ARTICLE; BACKACHE; BLEEDING; BURNING SENSATION; CLINICAL TRIAL; COMMON COLD; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; COST EFFECTIVENESS ANALYSIS; DISEASE EXACERBATION; DOSE RESPONSE; DRUG CHOICE; DRUG EFFICACY; DRY NOSE; ECZEMA; FATIGUE; FEMALE; GRASSLAND; HAY FEVER; HEADACHE; HISTAMINE RELEASE; HUMAN; HYPOTENSION; INFECTION; INSPIRATORY CAPACITY; MAJOR CLINICAL STUDY; MALE; MIGRAINE; NAUSEA; NOSE SECRETION; OPEN STUDY; PAIN; PARALLEL DESIGN; POLLEN ALLERGY; PRACTICE GUIDELINE; PREGNANCY COMPLICATION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SOMNOLENCE; STATISTICAL SIGNIFICANCE; STOMACH PAIN; VERTIGO;

EID: 25444490164     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)61225-2     Document Type: Article

References (19)

1. Bousquet J, Van Cauwenberge P, Khaltaev N; ARIA Workshop Group and World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108: S147-S334.
2. Braunstahl GJ, Fokkens W. Nasal involvement in allergic asthma. Allergy. 2003;58:1235-1243.
3. 1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ. 1998;317: 1624-1629.
4. Lange B, Bachert C. Topical nasal therapy of allergic rhinitis: an analysis of efficacy and costs [in German]. Allergologie. 2003;26:177-195.
5. 1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Ann Allergy Asthma Immunol. 2002;89:479-484.
6. Stempel DA, Thomas M. Treatment of allergic rhinitis: an evidence-based evaluation of nasal corticoids versus nonsedating antihistamines. Am J Manag Care. 1998;4:89-96.
7. Stempel DA, Woolf R. The cost of treating allergic rhinitis. Curr Allergy Asthma Rep. 2002;2:223-230.
8. Van Cauwenberge P, Bachert C, Passalacqua G, et al; European Academy of Allergology and Clinical Immunology. Consensus statement on the treatment of allergic rhinitis. Allergy. 2000;55: 116-134.
9. Van Cauwenberge P, Lund V, Bousquet J, El Akkad T. Profiles and symptom severity of patients presenting to general practice with seasonal allergic rhinitis [abstract 696]. Allergy. 2000; 55(suppl 63):197.
10. PDA/Center for Drug Evaluation and Research. Guidance for industry: allergic rhinitis: clinical development programs for drug products. Available at: http://www.fda.gov/cder/guidance/2718dft.htm. Accessed: November 1, 2002.
11. Wilson AM, Dempsey OJ, Sims EJ, et al. Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flow. Clin Exp Allergy. 2000; 30:833-838.
12. Bachert C, van Kempen M, Van Cauwenberge P. Regulation of proinflammatory cytokines in seasonal allergic rhinitis. Int Arch Allergy Immunol. 1999;118:375-379.
13. Machin D, Campbell MJ. Statistical Tables for the Design of Clinical Trials. Oxford, England: Blackwell Scientific Publications; 1987.
14. Orgel HA, Meltzer EO, Kemp JP, et al. Comparison of intranasal cromolyn sodium, 4%, and oral terfenadine for allergic rhinitis: symptoms, nasal cytology, nasal ciliary clearance, and rhinomanometry. Ann Allergy. 1991;66:237-244.
15. Weiss KB, Sullivan SB. The health economics of asthma and rhinitis, I: assessing the economic impact. J Allergy Clin Immunol. 2001;107:3-8.
16. Nash DB, Sullivan SD, Mackowiak J. Optimizing quality of care and cost effectiveness in treating allergic rhinitis in a managed care setting. Am J Manag Care. 2000;6:S3-S15.
17. Levine MA, Hamet P, Novosel S, Jolain B. A prospective comparison of four study designs used in assessing safety and effectiveness of drug therapy in hypertension management. Am J Hypertens. 1997;10:1191-1200.
18. Pajonk FG, Holzbach R, Naber D. Open studies in comparison to controlled studies in testing of neuroleptics [in German]. Fortschr Neurol Psychiatr. 2000;68:313-320.
19. Corren J. Intranasal corticosteroids for allergic rhinitis: how do different agents compare? J Allergy Clin Immunol. 1999;104: S144-S149.